Oct 01, 2018
Ocugen Initiates Phase 3 Clinical Trial of OCU310 for Dry Eye Disease
Sep 10, 2018
LUMIFY(TM) Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winner
Aug 06, 2018
Global Ophthalmic Drugs Market Forecast 2018-2028
May 02, 2018
Ocugen Presents Preclinical Efficacy Data of its Proprietary Nanoemulsion Technology at ARVO 2018
Apr 27, 2018
Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting
Apr 03, 2018
New Review of Early Clinical Experiences with Brinzolamide/Brimonidine Fixed Combination in Open-angle Glaucoma and Ocular Hypertension - touchOPHTHALMOLOGY
Mar 20, 2018
Ocugen Reports Positive Phase 2 Clinical Results Demonstrating Proof-of-Concept for its Novel Combination Therapy for Dry Eye Disease
Dec 22, 2017
Bausch + Lomb Receives FDA Approval of LUMIFY(TM) - The Only Over-The-Counter Eye Drop With Low-Dose Brimonidine For The Treatment Of Eye Redness
Sep 25, 2017
Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 (brimonidine/steroid combination therapy) and Initiates Proof of Concept Study for Treatment of Dry Eye Disease
Sep 11, 2017
Galderma: Combined Use of Rosacea Therapies Ivermectin 1% Cream and Brimonidine 0.33% Gel Evaluated in MOSAIC Study
Aug 09, 2017
Ocugen Receives FDA Orphan Drug Designation for OCU300 (brimonidine tartrate) for the Treatment of Ocular Graft Versus Host Disease
Aug 04, 2017
Perrigo Announces Tentative FDA Approval For Generic Version Of Mirvaso® Gel